Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.(CGON) | 859,050 | 1,004,050 | +145,000 | $21.04M | $26.11M | 32.34% | +$5.07M |
| Alumis Inc | 5,779,348 | 5,779,348 | 0 | $35.49M | $17.34M | 21.48% | -$18.15M |
| Disc Medicine, Inc.(IRON) | 299,069 | 299,069 | 0 | $14.85M | $15.84M | 19.62% | +$992.9K |
| Hims & Hers Health, Inc.CL A(HIMS) | 273,151 | 273,151 | 0 | $8.07M | $13.62M | 16.87% | +$5.54M |
| Maze Therapeutics, Inc.(MAZE) | 345,191 | 345,191 | 0 | $3.80M | $4.24M | 5.25% | +$434.9K |
| Lyell Immunopharma, Inc.(LYEL) | 0 | 406,652 | +406,652 | $0 | $3.59M | 4.45% | +$3.59M |
| Lyell Immunopharma, Inc.(LYEL) | 8,133,047 | 0 | -8,133,047 | $4.38M | $0 | — | -$4.38M |